Literature DB >> 9917185

How reliable/valid is dysplasia in identifying at-risk patients with ulcerative colitis?

R H Riddell1.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9917185     DOI： 10.1016/s1091-255x(98)80068-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  13 in total

1.  Ulcerative colitis and colorectal cancer. A population-based study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

2.  Can histopathologists reliably assess dysplasia in chronic inflammatory bowel disease?

Authors:  S A Dundas; R Kay; S Beck; D W Cotton; A J Coup; D N Slater; J C Underwood
Journal:  J Clin Pathol       Date:  1987-11       Impact factor: 3.411

3.  Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study.

Authors:  R Löfberg; O Broström; P Karlén; B Tribukait; A Ost
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

4.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

5.  Colorectal cancer surveillance in patients with ulcerative colitis.

Authors:  B Jonsson; L Ahsgren; L O Andersson; R Stenling; J Rutegård
Journal:  Br J Surg       Date:  1994-05       Impact factor: 6.939

6.  Dysplasia and carcinoma in longstanding ulcerative colitis: an endoscopic and histological surveillance programme.

Authors:  M Leidenius; I Kellokumpu; A Husa; M Riihelä; P Sipponen
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

7.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis.

Authors:  W R Connell; J E Lennard-Jones; C B Williams; I C Talbot; A B Price; K H Wilkinson
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

8.  Observer variation in the assessment of dysplasia in ulcerative colitis.

Authors:  M F Dixon; L J Brown; H M Gilmour; A B Price; N C Smeeton; I C Talbot; G T Williams
Journal:  Histopathology       Date:  1988-10       Impact factor: 5.087

Review 9.  Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?

Authors:  C N Bernstein; F Shanahan; W M Weinstein
Journal:  Lancet       Date:  1994-01-08       Impact factor: 79.321

10.  Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome.

Authors:  D M Melville; J R Jass; B C Morson; D J Pollock; P I Richman; N A Shepherd; J K Ritchie; S B Love; J E Lennard-Jones
Journal:  Hum Pathol       Date:  1989-10       Impact factor: 3.466
View more
  2 in total

1.  Combining aneuploidy and dysplasia for colitis' cancer risk assessment outperforms current surveillance efficiency: a meta-analysis.

Authors:  Rüdiger Meyer; Sandra Freitag-Wolf; Silke Blindow; Jürgen Büning; Jens K Habermann
Journal:  Int J Colorectal Dis       Date:  2016-10-20       Impact factor: 2.571

2.  Colorectal neoplasia in IBD--a single-center analysis of patients undergoing proctocolectomy.

Authors:  Rüdiger Meyer; Tilman Laubert; Martin Sommer; Claudia Benecke; Hendrik Lehnert; Klaus Fellermann; Hans-Peter Bruch; Tobias Keck; Christoph Thorns; Jens K Habermann; Jürgen Büning
Journal:  Int J Colorectal Dis       Date:  2015-04-26       Impact factor: 2.571
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.